Hjem › Myelofibrose › Florida › Miami
Kliniske studier for Myelofibrose i Miami, FL
10 studier for Myelofibrose søker deltakere på steder i og rundt Miami (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
RekruttererFase 1/2
- University of Miami, Miami
- Baptist Health - Miami Cancer Institute, Miami
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
RekruttererFase 3
- Miami NS Ins Baptist Health S FL, Miami
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
RekruttererFase 3
- Bioresearch Partners, Miami
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
RekruttererFase 2
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
RekruttererFase 1/2
- Sylvester Cancer Center - U Miami, Miami
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
RekruttererFase 1
- University of Miami, Miami
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
RekruttererFase 1
- University of Miami Health System, Miami
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
RekruttererFase 2
- University of Miami, Miami
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Miami
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
RekruttererFase 3
- University of Miami, Miami
Myelofibrose-studier i andre byer
- Houston, TX19 studier
- New York City, NY18 studier
- Boston, MA12 studier
- Durham, NC12 studier
- Columbus, OH11 studier
- Seattle, WA11 studier
- Salt Lake City, UT10 studier
- Atlanta, GA9 studier
- Tampa, FL9 studier
- Nashville, TN9 studier
- Cleveland, OH9 studier
- Baldwin Park, CA9 studier
Andre studier i Miami
- Brystkreft42 studier
- Kreft (alle typer)36 studier
- Ikke-småcellet lungekreft31 studier
- Prostatakreft27 studier
- Fedme27 studier
- Akut myelogen leukemi24 studier
- Metastatisk kreft24 studier
- Eggstokkreft23 studier
- Overvekt23 studier
- Multipelt myelom21 studier
- Ulcerøs kolitt21 studier
- Alzheimers sykdom20 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.